ERYTECH PHARMA (EPA:ERYP) ERYTECH Announces Conference Webcast to Discuss Results from Eryaspase Phase 2 Trial in Acute Lymphoblastic Leukemia to be Presented at the American Society of Hematology 2020 Annual Meeting
Transparency directive : regulatory news
03/12/2020 22:30